Diphtheria tetanus pertusis-hepatitis B vaccine - Bharat Biotech

Drug Profile

Diphtheria tetanus pertusis-hepatitis B vaccine - Bharat Biotech

Alternative Names: Comvac4; ComVac4-Hb; Diphtheria, tetanus, pertussis whole cell and recombinant hepatitis B vaccine - Bharat Biotech; DTwPHib - Bharat Biotech

Latest Information Update: 23 Jan 2018

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Bharat Biotech
  • Class Bacterial vaccines; Hepatitis B vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Marketed Diphtheria; Hepatitis B; Pertussis; Tetanus

Most Recent Events

  • 08 Jan 2018 Bharat Biotech completes a phase III trial in infant volunteers in India (IM) (CTRI2017-01-007706)
  • 19 Feb 2016 Launched for Diphtheria in India (IM) before February 2016 (Bharat Biotech pipeline; February 2016)
  • 19 Feb 2016 Launched for Hepatitis B in India (IM) (Bharat Biotech pipeline; February 2016)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top